GETI-B:STO
Getinge AB
SEK 247,20
arrow_downward
-0,32%(-0,80) 1D
1 okt, 17:29:44 GMT+2 · SEK
search
Alle symbolen
| Symbool | Prijs | Wijziging | Wijzigingspercentage |
|---|
insights_autoBelangrijkste inzichten voor GETI-B genereren…
Openen
SEK 246,00
Hoog
SEK 250,30
Laag
SEK 245,10
Beursw.
62,83 mld.
Gem. vol.
573,73K
Volume
361,28K
Dividend
1,92%
Kwartaaldividend
SEK 1,19
Ex-dividenddatum
22 apr 2026
Koers/winst-verhouding
25,18
52 wk hoog
SEK 251,40
52 wk laag
SEK 175,90
WPA
SEK 9,82
Uitstaande aandelen
254,15 mln.
Aantal medewerkers
12K
Openen
SEK 246,00
Hoog
SEK 250,30
Laag
SEK 245,10
Beursw.
62,83 mld.
Gem. vol.
573,73K
Volume
361,28K
Dividend
1,92%
Kwartaaldividend
SEK 1,19
Ex-dividenddatum
22 apr 2026
Koers/winst-verhouding
25,18
52 wk hoog
SEK 251,40
52 wk laag
SEK 175,90
WPA
SEK 9,82
Uitstaande aandelen
254,15 mln.
Aantal medewerkers
12K
Nieuwsartikelen
Van webbronnen en nieuwspartners
AD HOC NEWS
·
13 uur geleden
Getinge B stock ahead of the Xetra open: prior close EUR 21.81 on September 30, 2026
AD HOC NEWS
·
1 dag geleden
Pareto downgrades Getinge and keeps Getinge stock target at SEK 255.00
Profiel
Getinge AB is a publicly traded Swedish medical technology company. The company produces and distributes medical products and equipment for the healthcare and life sciences industries. The company is divided into three business areas: Life Science, Acute Care Therapies, and Surgical Workflows. The group employs approximately 12,000 people worldwide. The CEO of the company is Mattias Perjos, and the chairman of the board is Johan Malmquist. With a sales share of around 40%, the United States is by far the most important market for the company due to significantly higher prices and margins there. China and various Western European countries follow. Wikipedia
Over Getinge AB